Reactivation of viral replication after liver resection in patients infected with hepatitis B virus

Annals of Surgery

Volumn 233, Issue 1, 2001, Pages 139-145

  Kubo, Shoji ^a   Nishiguchi, Shuhei ^a   Hamba, Hiroyuki ^a   Hirohashi, Kazuhiro ^a   Tanaka, Hiromu ^a   Shuto, Taichi ^a   Kinoshita, Hiroaki ^a   Kuroki, Tetsuo ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ADULT; AGED; ARTICLE; ENZYME ACTIVITY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; VIRUS REPLICATION;

ADULT; AGED; ALANINE TRANSAMINASE; CARCINOMA, HEPATOCELLULAR; DNA, VIRAL; FEMALE; HEPATECTOMY; HEPATITIS B; HEPATITIS B ANTIGENS; HUMANS; LIVER; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; RISK FACTORS; STATISTICS, NONPARAMETRIC; VIRUS REPLICATION;

EID: 0035159737     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-200101000-00020     Document Type: Article

References (44)

1. Decreased morbidity and mortality rates in surgical patients with hepatocellular carcinoma
2. Hepatic resection for hepatocellular carcinoma: An audit of 343 patients
3. Transection of the oesophagus for bleeding oesophageal varices
4. A multiple regression equation for prediction of posthepatectomy liver failure
5. Preoperative estimation of surgical risk of hepatectomy in cirrhotic patients
6. Resection of hepatocellular carcinomas: Results in 72 European patients with cirrhosis
7. Can hepatic failure after surgery for hepatocellular carcinoma in cirrhotic patients be prevented?
8. Estimations of risk of major complications after hepatic resection
9. Hepatocellular carcinoma and cirrhosis: Results of surgical treatment in a European series
10. Surgical resection of hepatocellular carcinoma in cirrhotic patients: Prognosis value of preoperative portal pressure
11. Measurement of liver volume and hepatic functional reserve as a guide in decision-making in resectional surgery for hepatic tumors
12. Hepatitis B virus precore mutant infection in associated with severe recurrent disease after liver transplantation
13. Randomised trial of effects of interferon-α on incidence of hepatocellular carcinoma on chronic active hepatitis C with cirrhosis
14. Poor association of GBV-C viremia with hepatocellular carcinoma
15. Quantitative analysis of wild-type and HBeAg-minus hepatitis B viruses by a sequence-dependent primer extension assay
16. Classification of chronic hepatitis: Diagnosis, grading and staging
17. Intrahepatic distribution of hepatitis B surface and core antigens in chronic hepatitis B virus infection: Hepatocyte with cytoplasmic/membranous hepatitis B core antigens as a possible target for immune hepatocytolysis
18. Precore mutant hepatitis B virus infection and liver disease
19. Correlation of hepatitis B virus DNA and antigens in the liver: A study in chronic liver disease
20. GB virus C infection by blood transfusion during and following surgery
21. Primary liver cancer in Japan: Clinicopathological features and results of surgical treatment
22. Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection: Incidence, predisposing factors and etiology
23. Serial studies of hepatitis-associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders
24. Reactivation of chronic hepatitis B virus infection by cancer chemotherapy
25. Massive hepatic necrosis after chemotherapy withdrawal in a hepatitis B virus carrier
26. Fulminant hepatitis due to reactivation of chronic hepatitis B virus infection after allogeneic bone marrow transplantation
27. Acute liver decompensation on withdrawal of cytotoxic chemotherapy and immunosuppressive therapy in hepatitis B carriers
28. Fatal reactivation of chronic hepatitis B virus infection following withdrawal of chemotherapy in lymphoma patients
29. Chemotherapy and hepatitis B
30. Fulminant hepatitis as a consequence of reactivation of hepatitis B virus infection after discontinuation of low-dose methotrexate therapy
31. Reactivation of hepatiti B virus replication in patients receiving cytotoxic therapy: Report of a prospective study
32. Reactivation of precore mutant hepatitis B virus leading to fulminant hepatic failure following cytotoxic treatment
33. Effects of immunosuppresive therapy on viral markers in chronic active hepatitis B
34. Effect of short-term prednisone therapy on aminotransferase levels and hepatitis B virus markers in chronic type B hepatitis
35. A pilot study on the effects of predonisone withdrawal on serum hepatitis B virus DNA and HBeAg in chronic active hepatitis B
36. Homeostasis: Bodily changes in trauma and surgery
37. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis
38. A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis
39. Association of precore genomic variant of hepatitis B virus with fulminant hepatitis
40. Nucleotide sequence analysis of the precore region in patients with fulminant hepatitis B in the United States
41. Inhibition by interferon (α + β) of mouse liver regeneration and its reversal by putrescine
42. Liver transplantation for fulminant hepatitis following chemotherapy for malignant lymphoma